Processing math: 100%
Development of Machine Learning Regression Model for COVID-19 Drug Target Prediction | IEEE Conference Publication | IEEE Xplore

Development of Machine Learning Regression Model for COVID-19 Drug Target Prediction


Abstract:

There is a perennial need to identify novel, effective therapeutic agents to combat rising infections. Recently, prediction of therapeutic targets to decrease the impact ...Show More

Abstract:

There is a perennial need to identify novel, effective therapeutic agents to combat rising infections. Recently, prediction of therapeutic targets to decrease the impact of COVID-19 has posed an urgent challenge requiring innovative solutions. Successful identification of novel drug-target combinations may greatly facilitate drug development. To meet this need, we developed a COVID-19 drug target prediction model using machine learning approaches to quickly identify drug candidates for 18 COVID-19 protein targets. Specifically, we analyzed the performance of three prediction models to predict drug-target docking scores, which represents the strength of interactions between ligands and proteins. Docking scores were predicted for 300,457 molecules on 18 different COVID-19 related protein docking targets. Our proposed approach achieved a competitive performance with \mathrm{R}^{2}=0.69,MAE=0.285, MSE=0.627. In addition, we identify chemical structures associated with stronger binding affinities across target binding sites. We believe our work could potentially save pharmaceutical companies significant resources, especially during the early stages of drug development.
Date of Conference: 06-08 December 2022
Date Added to IEEE Xplore: 02 January 2023
ISBN Information:
Conference Location: Las Vegas, NV, USA

Contact IEEE to Subscribe

References

References is not available for this document.